Tech Company Financing Transactions

Archemix Funding Round

Archemix, based in Cambridge, raised $29.8 million from Atlas Venture, Highland Capital Partners and Prospect Venture Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

148 Sidney St.
Cambridge, MA 02139
USA

Phone

(617) 621-7700

Website

www.archemix.com

Email Address

[email protected]

Overview

The company is leading the development of aptamers as a new class of directed therapeutics for the prevention and treatment of chronic and acute diseases. With their unique properties, aptamers offer an alternative to biologics and small molecules in numerous applications and hold extraordinary potential to address unmet medical needs.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ken Bate

        

VP - Bus. Development

John Harre

        

VP - R & D

Robert Schaub

        

Browse more venture capital transactions:

Prev: 6/30/2007: Active Optical MEMS venture capital transaction
Next: 6/30/2007: Previstar venture capital transaction

Share this article

Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary